Dustin Haines
Gilead Sciences names its new health leader for Asia markets
Gilead Sciences names its new health leader for Asia markets
Dustin Haines has 20 years leadership in pharmaceuticals.
Most Read
1. NHG Health unveils Serangoon Polyclinic in Singapore 2. Chang Gung Hospital targets bigger Philippine patient base 3. Singapore–Malaysia medtech pilot seen luring more regional investment 4. Medical membranes market to be valued at $6.66b by 2030 5. SGH launches neuroscience ICU to support critical casesResource Center
Read Here
Advertise
Sign Up
Awards
Mar
26
Events
Event News
Healthcare Asia Awards 2025 Winner: Lee Ligang Zhang of iKang Healthcare Group
Lee Ligang Zhang of iKang Healthcare Group highlights how AI and precision diagnosis are transforming healthcare delivery today.
